Clinical Trial Update: Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DM [Phase 1]

View source ↗

Summary

The document reports a terminated Phase 1 study assessing concentrations of saxagliptin, its 5-hydroxy metabolite, and metformin in pediatric patients with Type…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• 5-Hydroxy Saxagliptin (5-hydroxy saxagliptin)
• Saxagliptin (saxagliptin)
• metformin (metformin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: TERMINATED | Results posted: 2014-08-26